Is Evogene Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Evogene Ltd (EVGN) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Evogene Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Evogene Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Evogene Ltd?

Muslim investors may consider investing in Evogene Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Evogene Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Evogene Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Evogene Ltd updated?

The Shariah compliance status of Evogene Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Evogene Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Evogene Ltd?

You can check the latest Shariah compliance status of Evogene Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

EVGN Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 17, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Evogene Ltd (EVGN)

Based on 7 analysts giving stock ratings to Evogene Ltd in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Evogene Ltd. Stock Analysis EVGN

United States Health Care Nano Cap Report: 2025 Annual

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 142 full-time employees. The company went IPO on 2007-06-11. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.

Key Statistics of Evogene Ltd (EVGN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.71$0.75

Today's Open

$0.72

Volume

30.38K

P/E Ratio (TTM)

52 Week Range

$0.71$2.42

Market Cap

7.63M

Avg. Volume

50.11K

Dividend Yield

Financial Metrics & Statements of Evogene Ltd (EVGN)

FAQ's for Evogene Ltd (EVGN)

According to Musaffa’s Shariah screening methodology, Evogene Ltd (EVGN) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.